Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for mk 2206 (compound)
Most Correlated Studies
- Non-small cell lung cancer NCI-H1666 cells infected with Influenza A(H1N1) and treated with MK2206
- Breast cancer cell lines and xenografts treated with PI3KA or AKT inhibitors
- Breast duct carcinoma T-47D cells treated with AKT inhibitor MK2206
- Osteosarcoma U-2 OS cells treated with 6 different small molecules
- Prostate cancer mouse models treated with different compounds
Most Relevant Literature
- MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Gro…
- A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma.
- Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chron…
- Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated end…
- Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancre…
Most Relevant Clinical Trials
- A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tu…
- A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Ad…
- Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-…
- Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for …
- Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
